Which hedge funds own GMED? GLOBUS MED INC, Q2 2026 13F holders
40 tracked hedge funds disclosed a position in GMED (GLOBUS MED INC) in their Q2 2026 13F filings, worth $805.9m in total. The largest holder by portfolio weight is Sio Capital Management, LLC at 4.1% of its book. 4 opened a new position this quarter: Sio Capital Management, LLC, AlphaGrep UK Ltd, Renaissance Technologies LLC, Cinctive Capital Management LP. 26 exited: Parsifal Capital Management, LP, Hawk Ridge Capital Management LP, Old West Investment Management, LLC.
- 40
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 4
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 26
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $40.0m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $325m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $806m
- Combined value Sum of the holders' reported positions in the security.
- 3.2%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Parsifal Capital Management, LP | 4.3% | $33.4m |
| Hawk Ridge Capital Management LP | 1.6% | $43.1m |
| Old West Investment Management, LLC | 0.7% | $6.3m |
| Campbell & CO Investment Adviser LLC | 0.3% | $4.8m |
| ExodusPoint Capital Management, LP | 0.2% | $18.0m |
| Okabena Investment Services Inc | 0.2% | $843k |
| PFM Health Sciences, LP | 0.2% | $1.5m |
| Citadel Advisors LLC | 0.1% | $169m |
| iSAM Funds (UK) Ltd | 0.1% | $223k |
| Hillsdale Investment Management Inc. | 0.1% | $3.7m |
| Edgestream Partners, L.P. | 0.06% | $1.9m |
| Numerai GP LLC | 0.05% | $504k |
| Verition Fund Management LLC | 0.04% | $3.9m |
| Y-Intercept (Hong Kong) Ltd | 0.04% | $2.0m |
| Capital Fund Management S.A. | 0.03% | $3.6m |
| Candriam S.C.A. | 0.03% | $5.1m |
| Qube Research & Technologies Ltd | 0.02% | $16.9m |
| Aquatic Capital Management LLC | 0.02% | $788k |
| Maverick Capital Ltd | 0.02% | $1.3m |
| Quantbot Technologies LP | 0.01% | $349k |
| Gsa Capital Partners LLP | 0.01% | $219k |
| Balyasny Asset Management L.P. | 0.01% | $5.5m |
| Trexquant Investment LP | 0.01% | $828k |
| Capstone Investment Advisors, LLC | 0.0% | $397k |
| Farallon Capital Management, L.L.C. | 0.0% | $345k |
| IFM Investors Pty Ltd | 0.0% | $2.3k |
Ownership over time
Who discovered GMED first? Beta
| Pura Vida Investments, LLC high conviction | Q2 2017 | +2.9 pts |
| J. Goldman & Co LP | Q1 2023 | +1.2 pts |
| First Light Asset Management, LLC | Q3 2017 | +1.1 pts |
| Integral Health Asset Management, LLC | Q2 2021 | +0.5 pts |
| Hawk Ridge Capital Management LP high conviction | Q1 2023 | +0.3 pts |
| Sivik Global Healthcare LLC | Q1 2021 | 0.0 pts |
| RTW Investments, LP | Q4 2020 | −0.2 pts |
| Sio Capital Management, LLC high conviction | Q2 2023 | −1.5 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.